Physician profile
Daniel Sohinki
NPI 1992094106
$14,221.10
in general payments reported to CMS, 2019-2025
18 companies · $790 in 2025
The $790 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,187 · 2020: $293 · 2021: $2,148 · 2022: $3,958 · 2023: $2,111 · 2024: $735 · 2025: $790.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,450 · Travel and Lodging: $1,172 · Entertainment: $13.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,450.35 |
| Travel and Lodging | $1,171.83 |
| Entertainment | $13.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $3,559.06 | 2021-2025 | Atriclip Laa Exclusion System, Atricure Cryoice Cryoablation System (Cryo2) |
| Boston Scientific Corporation | $3,220.14 | 2019-2025 | Resonate El Icd Vr, General - Therapies, General - Tachy |
| Medtronic Vascular, INC. | $2,535.82 | 2019-2020 | |
| Medtronic, INC. | $2,467.72 | 2021-2025 | Micra, Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan |
| Biosense Webster, INC. | $1,412.02 | 2019-2025 | Carto 3, Qdot Micro Catheter |
| Cardiva Medical, INC. | $337.47 | 2021-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Ensoetm, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Stereotaxis INC | $166.06 | 2019-2024 | Genesis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $126.87 | 2019-2023 | Lifevest |
| Abbott Laboratories | $112.01 | 2021-2024 | Ensite |
| Janssen Pharmaceuticals, INC | $89.26 | 2020-2024 | Xarelto |
| Philips North America LLC | $55.51 | 2022 | |
| Kestra Medical Technology Services, INC. | $28.29 | 2025 | Assure Wcd |
| Inspire Medical Systems, INC. | $21.17 | 2025 | Inspire |
| Amgen INC. | $20.74 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.14 | 2025 | Jardiance |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $18.23 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.35 | 2024 | |
| Merck Sharp & Dohme LLC | $15.24 | 2023 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Sohinki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.